Zacks Investment Research on MSN
PacBio & Lucid Genomics partner to boost data analysis, stock up
PacBio PACB recently announced a compatibility collaboration with Lucid Genomics, bringing the latter into its Compatible ...
Recent advances in artificial intelligence are reshaping genomics, with new tools enabling faster, more accurate genome annotation, variant detection, and functional prediction across agriculture and ...
The clinical interpretation of genetic testing results remains one of the most significant hurdles in effectively applying genomics in modern medicine. Errors in variant interpretation, whether false ...
Expands access to streamlined genomic data analysis across the PacBio partner ecosystemMENLO PARK, Calif. & BERLIN, April 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a premier developer of ...
Advances in sequencing technologies allow scientists to uncover unique somatic and germline mutations that drive cancer. However, the large amount of data and complex bioinformatics involved in ...
Researchers have introduced an algorithm based on deep learning that can predict the effects of rare genetic variants. The method allows persons with high risk of disease to be distinguished more ...
Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However, particularly in the case of genetic variants that only rarely occur in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results